NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,450 | -31.0% | 300 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $18,042 | -18.0% | 300 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $22,005 | -29.0% | 300 | -25.0% | 0.01% | -25.0% |
| Q3 2022 | $31,000 | +55.0% | 400 | 0.0% | 0.01% | +60.0% |
| Q2 2022 | $20,000 | -20.0% | 400 | +33.3% | 0.01% | -16.7% |
| Q1 2022 | $25,000 | +8.7% | 300 | 0.0% | 0.01% | +20.0% |
| Q4 2021 | $23,000 | -34.3% | 300 | 0.0% | 0.01% | -44.4% |
| Q3 2021 | $35,000 | -47.8% | 300 | 0.0% | 0.01% | -50.0% |
| Q2 2021 | $67,000 | +67.5% | 300 | 0.0% | 0.02% | +50.0% |
| Q1 2021 | $40,000 | -23.1% | 300 | 0.0% | 0.01% | -29.4% |
| Q4 2020 | $52,000 | +57.6% | 300 | 0.0% | 0.02% | +41.7% |
| Q3 2020 | $33,000 | +83.3% | 300 | 0.0% | 0.01% | +71.4% |
| Q2 2020 | $18,000 | -10.0% | 300 | 0.0% | 0.01% | -22.2% |
| Q1 2020 | $20,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |